Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...
Hormones may be leveraged to treat and prevent signs of aging such as wrinkles and hair graying, according to a new study published in the Endocrine Society journal Endocrine Reviews. Until now ...
News-Medical.Net on MSN1d
Fatty liver disease linked to higher mortality risk from many common diseasesA comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...
Feb 28 (Reuters) - The European Union's health regulator on Friday backed AstraZeneca (AZN.L), opens new tab and Daiichi Sankyo's (4568.T), opens new tab drug Enhertu as a breast cancer treatment ...
Vanotech Ltd, a pharmaceutical company devoted to greatly improving the lives of people living with Ophthalmic, central nervous, digestive and endocrine conditions using innovative science that ...
Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025MBX 1416 Phase 2 trial in ...
DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a targeted treatment known as ...
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the global CDK4/6 inhibitor market remains highly competitive ...
Matthew Frederick Nobiesse Laboratories, LLC +1 917-224-8124 email us here Visit us on social media: Facebook X LinkedIn Instagram YouTube TikTok Legal Disclaimer: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback